Literature DB >> 19571673

Wrap53, a novel regulator of p53.

Marianne Farnebo1.   

Abstract

Natural antisense transcripts are a group of regulatory RNAs whose existence has been known for a long time but whose functional significance is still relatively unknown. Studies indicate that a large fraction of all mammalian genes may be regulated by antisense transcripts suggesting a central role of this regulation in eukaryotic gene expression. Wrap53 is a natural antisense transcript of p53 that regulates endogenous p53 mRNA levels and is furthermore required for induction of p53 protein by targeting the 5'untranslated region of p53 mRNA. Our discovery of Wrap53 demonstrates for the first time that an antisense transcript has an essential role in the regulation of p53 mRNA. This finding provides important new insight into p53 regulation and the mechanism of antisense-mediated gene regulation in human cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571673     DOI: 10.4161/cc.8.15.9223

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

Review 1.  Minireview: Switching on progesterone receptor expression with duplex RNA.

Authors:  Bethany A Janowski; David R Corey
Journal:  Mol Endocrinol       Date:  2010-06-30

2.  Single-strand conformational polymorphism analysis of a common single nucleotide variation in WRAP53 gene, rs2287499, and evaluating its association in relation to breast cancer risk and prognosis among Iranian-Azeri population.

Authors:  Aida Sedaie Bonab; Nasser Pouladi; Mohammad Ali Hosseinpourfeizi; Reyhaneh Ravanbakhsh Gavgani; Roghayeh Dehghan; Parvin Azarfam; Vahid Montazeri; Ashraf Fakhrjou
Journal:  Med Oncol       Date:  2014-08-19       Impact factor: 3.064

3.  Structure and expression of two nuclear receptor genes in marsupials: insights into the evolution of the antisense overlap between the α-thyroid hormone receptor and Rev-erbα.

Authors:  Brandon C Rindfleisch; M Scott Brown; John L VandeBerg; Stephen H Munroe
Journal:  BMC Mol Biol       Date:  2010-12-10       Impact factor: 2.946

4.  Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Authors:  Jackson R Taylor; Brian D Lehmann; William H Chappell; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2011-08

5.  The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair.

Authors:  Sofia Henriksson; Hanif Rassoolzadeh; Elisabeth Hedström; Christos Coucoravas; Alexander Julner; Michael Goldstein; Gabriela Imreh; Boris Zhivotovsky; Michael B Kastan; Thomas Helleday; Marianne Farnebo
Journal:  Genes Dev       Date:  2014-12-15       Impact factor: 11.361

Review 6.  On the road with WRAP53β: guardian of Cajal bodies and genome integrity.

Authors:  Sofia Henriksson; Marianne Farnebo
Journal:  Front Genet       Date:  2015-03-24       Impact factor: 4.599

7.  Association of common WRAP 53 variant with ovarian cancer risk in the Polish population.

Authors:  Krzysztof Mędrek; Piotr Magnowski; Bartłomiej Masojć; Anita Chudecka-Głaz; Bogdan Torbe; Janusz Menkiszak; Marek Spaczyński; Jacek Gronwald; Jan Lubiński; Bohdan Górski
Journal:  Mol Biol Rep       Date:  2012-11-29       Impact factor: 2.316

8.  Accumulation of splice variants and transcripts in response to PI3K inhibition in T cells.

Authors:  Alice Riedel; Boitumelo Mofolo; Elita Avota; Sibylle Schneider-Schaulies; Ayton Meintjes; Nicola Mulder; Susanne Kneitz
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

9.  Overexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinoma.

Authors:  Xuguang Rao; Daofu Huang; Xuxia Sui; Gefei Liu; Xuhong Song; Jinglian Xie; Dongyang Huang
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas.

Authors:  Chong-kui Sun; Xiao-bo Luo; Ya-ping Gou; Ling Hu; Kun Wang; Chao Li; Zhen-ting Xiang; Ping Zhang; Xiang-li Kong; Chao-liang Zhang; Qin Yang; Jing Li; Li-ying Xiao; Yan Li; Qian-ming Chen
Journal:  Mol Cancer       Date:  2014-07-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.